An advisory panel to the F.D.A. will consider Pfizer’s application for those ages 5-to-11 on Tuesday.
Published: October 24, 2021 at 07:50PM
from NYT Health https://ift.tt/2XG2SKp
An advisory panel to the F.D.A. will consider Pfizer’s application for those ages 5-to-11 on Tuesday.
Published: October 24, 2021 at 07:50PM
from NYT Health https://ift.tt/2XG2SKp